Partial regulatory T cell depletion prior to schistosomiasis vaccination does not enhance the protection

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Wang, Xuefeng ^a   Liu, Fan ^b   Zhou, Sha ^c   Xu, Zhipeng ^c   Hoellwarth, Jason ^d   Chen, Xiaojun ^c   He, Lei ^c   Zhang, Rongbo ^a   Liu, Feng ^c   Wang, Jun ^a   Su, Chuan ^c  

^a ANHUI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b XIAMEN UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR ALPHA ANTIBODY; INTERLEUKIN 2 RECEPTOR ANTIBODY; INTERLEUKIN 4; PLASMID VECTOR; PVAX1 SCHISTOSOMA JAPONICUM 26 KDA GLUTATHIONE S TRANSFERASE DNA; SCHISTOSOMA VACCINE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMORAL IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SCHISTOSOMIASIS JAPONICA; SPLEEN CELL; T CELL DEPLETION; UPREGULATION; VACCINATION;

ANIMALS; FEMALE; GLUTATHIONE TRANSFERASE; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; T-LYMPHOCYTES, REGULATORY; VACCINATION;

MUS; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

EID: 84863618376     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040359     Document Type: Article

References (60)

1. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, et al. (2008) Helminth infections: the great neglected tropical diseases. J Clin Invest 118: 1311-1321.
2. King CH, (2009) Toward the elimination of schistosomiasis. N Engl J Med 360: 106-109.
3. Doenhoff MJ, Cioli D, Utzinger J, (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21: 659-667.
4. Abdul-Ghani R, Loutfy N, el-Sahn A, Hassan A, (2009) Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges. Parasitol Res 104: 955-965.
5. Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming FM, et al. (2009) The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 136: 1719-1730.
6. McManus DP, Loukas A, (2008) Current status of vaccines for schistosomiasis. Clin Microbiol Rev 21: 225-242.
7. Bergquist NR, Leonardo LR, Mitchell GF, (2005) Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol 21: 112-117.
8. Aloysius MM, Mc Kechnie AJ, Robins RA, Verma C, Eremin JM, et al. (2009) Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs. J Transl Med 7: 18.
9. Toka FN, Suvas S, Rouse BT, (2004) CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. J Virol 78: 13082-13089.
10. Belkaid Y, (2007) Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 7: 875-888.
11. Layland LE, Mages J, Loddenkemper C, Hoerauf A, Wagner H, et al. (2010) Pronounced phenotype in activated regulatory T cells during a chronic helminth infection. J Immunol 184: 713-724.
12. Wang X, Zhou S, Chi Y, Wen X, Hoellwarth J, et al. (2009) CD4+CD25+ Treg induction by an HSP60-derived peptide SJMHE1 from Schistosoma japonicum is TLR2 dependent. Eur J Immunol 39: 3052-3065.
13. Maizels RM, Smith KA, (2011) Regulatory T cells in infection. Adv Immunol 112: 73-136.
14. Cabrera G, Mundinano J, Camicia G, Costa H, Nepomnaschy I, et al. (2011) [Regulatory T cell depletion increases the number of CD8 cells during mouse mammary tumor virus infection.]. Medicina (B Aires) 71: 243-246.
15. Dietze KK, Zelinskyy G, Gibbert K, Schimmer S, Francois S, et al. (2011) Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points. Proc Natl Acad Sci U S A 108: 2420-2425.
16. Rech AJ, Vonderheide RH, (2009) Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells. Ann N Y Acad Sci 1174: 99-106.
17. Dannull J, Su Z, Rizzieri D, Yang BK, Coleman D, et al. (2005) Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 115: 3623-3633.
18. Jing W, Yan X, Hallett WH, Gershan JA, Johnson BD, (2011) Depletion of CD25+ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma. Blood 117: 6952-6962.
19. Tuettenberg A, Schmitt E, Knop J, Jonuleit H, (2007) Dendritic cell-based immunotherapy of malignant melanoma: success and limitations. J Dtsch Dermatol Ges 5: 190-196.
20. Hoon DS, Foshag LJ, Nizze AS, Bohman R, Morton DL, (1990) Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamide. Cancer Res 50: 5358-5364.
21. Hong H, Gu Y, Zhang H, Simon AK, Chen X, et al. (2010) Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in a murine mammary breast cancer model. Clin Exp Immunol 159: 93-99.
22. Tabbara KS, Peters NC, Afrin F, Mendez S, Bertholet S, et al. (2005) Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection. Infect Immun 73: 4714-4722.
23. Furuichi Y, Tokuyama H, Ueha S, Kurachi M, Moriyasu F, et al. (2005) Depletion of CD25+CD4+T cells (Tregs) enhances the HBV-specific CD8+ T cell response primed by DNA immunization. World J Gastroenterol 11: 3772-3777.
24. Tiu WU, Davern KM, Wright MD, Board PG, Mitchell GF, (1988) Molecular and serological characteristics of the glutathione S-transferases of Schistosoma japonicum and Schistosoma mansoni. Parasite Immunol 10: 693-706.
25. Wei F, Liu Q, Gao S, Shang L, Zhai Y, et al. (2008) Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26 kDa GST plasmid DNA vaccine in mice. Vaccine 26: 4145-4149.
26. Mikkelsen SR, Long JM, Zhang L, Galemore ER, VandeWoude S, et al. (2011) Partial regulatory T cell depletion prior to acute feline immunodeficiency virus infection does not alter disease pathogenesis. PLoS One 6: e17183.
27. Matsushita N, Pilon-Thomas SA, Martin LM, Riker AI, (2008) Comparative methodologies of regulatory T cell depletion in a murine melanoma model. J Immunol Methods 333: 167-179.
28. Turner JD, Jenkins GR, Hogg KG, Aynsley SA, Paveley RA, et al. (2011) CD4+CD25+ regulatory cells contribute to the regulation of colonic Th2 granulomatous pathology caused by schistosome infection. PLoS Negl Trop Dis 5: e1269.
29. Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, et al. (2007) Immunopathology of schistosomiasis. Immunol Cell Biol 85: 148-154.
30. Dunne DW, Cooke A, (2005) A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol 5: 420-426.
31. Macatangay BJ, Szajnik ME, Whiteside TL, Riddler SA, Rinaldo CR, (2010) Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART. PLoS One 5: e9852.
32. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, et al. (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59: 3128-3133.
33. Kim B, Feng N, Narvaez CF, He XS, Eo SK, et al. (2008) The influence of CD4+ CD25+ Foxp3+ regulatory T cells on the immune response to rotavirus infection. Vaccine 26: 5601-5611.
34. Li MJ, Lei JH, Wang T, Lu SJ, Guan F, et al. (2011) Cimetidine enhances the protective effect of GST DNA vaccine against Schistosoma japonicum. Exp Parasitol 128: 427-432.
35. Cardoso LS, Oliveira SC, Goes AM, Oliveira RR, Pacifico LG, et al. (2010) Schistosoma mansoni antigens modulate the allergic response in a murine model of ovalbumin-induced airway inflammation. Clin Exp Immunol 160: 266-274.
36. Chuang CM, Hoory T, Monie A, Wu A, Wang MC, et al. (2009) Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells. Vaccine 27: 684-689.
37. Taylor MD, LeGoff L, Harris A, Malone E, Allen JE, et al. (2005) Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol 174: 4924-4933.
38. Tuve S, Chen BM, Liu Y, Cheng TL, Toure P, et al. (2007) Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses. Cancer Res 67: 5929-5939.
39. Stober CB, Lange UG, Roberts MT, Alcami A, Blackwell JM, (2005) IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J Immunol 175: 2517-2524.
40. Welters MJ, Kenter GG, de Vos van Steenwijk PJ, Lowik MJ, Berends-van der Meer DM, et al. (2010) Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses. Proc Natl Acad Sci U S A 107: 11895-11899.
41. Schoenborn JR, Wilson CB, (2007) Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96: 41-101.
42. Couper KN, Blount DG, Riley EM, (2008) IL-10: the master regulator of immunity to infection. J Immunol 180: 5771-5777.
43. van der Vlugt LE, Labuda LA, Ozir-Fazalalikhan A, Lievers E, Gloudemans AK, et al. (2012) Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS One 7: e30883.
44. Anderson CF, Oukka M, Kuchroo VJ, Sacks D, (2007) CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204: 285-297.
45. Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, et al. (2007) Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204: 273-283.
46. Fujio K, Okamura T, Yamamoto K, (2010) The Family of IL-10-secreting CD4+ T cells. Adv Immunol 105: 99-130.
47. Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN, (2007) Regulatory T cells and human disease. Clin Dev Immunol 2007: 89195.
48. Jankovic D, Kugler DG, Sher A, (2010) IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol 3: 239-246.
49. Liu XS, Leerberg J, MacDonald K, Leggatt GR, Frazer IH, (2009) IFN-gamma promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host. J Immunol 183: 51-58.
50. McManus DP, (2005) Prospects for development of a transmission blocking vaccine against Schistosoma japonicum. Parasite Immunol 27: 297-308.
51. Capron A, Riveau G, Capron M, Trottein F, (2005) Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol 21: 143-149.
52. Brooks DG, Lee AM, Elsaesser H, McGavern DB, Oldstone MB, (2008) IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J Exp Med 205: 533-541.
53. Kaufman HL, Kim DW, DeRaffele G, Mitcham J, Coffin RS, et al. (2010) Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma. Ann Surg Oncol 17: 718-730.
54. Toossi Z, Hirsch CS, Wu M, Mayanja-Kizza H, Baseke J, et al. (2011) Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation. Clin Exp Immunol 163: 333-338.
55. McAleer JP, Vella AT, (2010) Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide. Trends Immunol 31: 429-435.
56. Bhowmick S, Mazumdar T, Ali N, (2009) Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection. Infect Immun 77: 1514-1523.
57. Li YS, Ross AG, Sleigh AC, Li Y, Waine GJ, et al. (1999) Antibody isotype responses, infection and re-infection for Schistosoma japonicum in a marshland area of China. Acta Trop 73: 79-92.
58. Wang X, Zhang L, Chi Y, Hoellwarth J, Zhou S, et al. (2010) The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy. Parasit Vectors 3: 109.
59. Zhang L, Yang Y, Yang X, Zhao J, Yang J, et al. (2008) T cell epitope-based peptide-DNA dual vaccine induces protective immunity against Schistosoma japonicum infection in C57BL/6J mice. Microbes Infect 10: 251-259.
60. Fecci PE, Sweeney AE, Grossi PM, Nair SK, Learn CA, et al. (2006) Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells. Clin Cancer Res 12: 4294-4305.